Previous 10 | Next 10 |
– Samir Gharib, MBA, Promoted to President – Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today an...
Can you handle risk? Do you like volatility? If you answered yes to either question, then penny stocks are probably something to watch. These low-priced equities have become a go-to for profit hunters looking for quick gains. But those gains come with plenty of risks. Just as quickly as the...
Gainers: PyroGenesis Canada (NASDAQ:PYR) +72%. Microbot Medical MBOT +50%. CollPlant Biotechnologies CLGN +32%. Future FinTech FTFT +41%. American Virtual Cloud Technologies (NASDAQ:AVCT) +23%. Spruce Biosciences (NASDAQ:SPRB) +31%. Tarena International TEDU +19%. CNF...
Gainers: BiondVax (NASDAQ:BVXV) +96%. SeaChange (NASDAQ:SEAC) +46%. Acasti (NASDAQ:ACST) +43%. Society Pass (NASDAQ:SOPA) +30%. ALJ Regional Holdings (NASDAQ:ALJJ) +26%. Red Cat (OTCQB:RCAT) +23%. Getnet Adquirencia (NASDAQ:GET) +23%. Lottery (NASDAQ:LTRY) +20%. Bellerophon Therapeutics (NASD...
Penny Stocks Article TL;DR Overview – High short interest is something that retail traders seek to find stocks that may hold potential for aggressively bullish swings. – When penny stocks experience a short squeeze, that can compound momentum in the mar...
Gainers: Society Pass Incorporated Common SOPA +260%. Bluerock Residential Growth REIT BRG +71%. Can-Fite BioPharma CANF +67%. Galera Therapeutics (NASDAQ:GRTX) +42%. AeroClean Technologies. (NASDAQ:AERC) +38%. Losers: Summit Therapeutics SMMT -...
Gainers: Society Pass (NASDAQ:SOPA) +237%. Bluerock Residential Growth (NYSE:BRG) +71%. Can-Fite (NYSE:CANF) +59%. AeroClean (NASDAQ:AERC) +58%. Galera Therapeutics (NASDAQ:GRTX) +38%. Verso (NYSE:VRS) +35%. Roivant (NASDAQ:ROIV) +26%. Venus (NASDAQ:VERO) +25%. BioCardia (NASDAQ:BCDA) +1...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks ended the week on a down note after the simultaneous expiration of single-stock options, single-stock futures, and stock-index options, and stock-fu...
GAINERS: SK Telecom (NYSE:SKM) +74%. Genfit (NASDAQ:GNFT) +59%. Spruce Biosciences (NASDAQ:SPRB) +54%. Stran & Company. Warrant (NASDAQ:STRNW) +34%. Bellerophon Therapeutics (NASDAQ:BLPH) +31%. LOSERS: Pasithea Therapeutics (NASDAQ:KTTA) -17%. Metacrine (N...
Gainers: SK Telecom (NYSE:SKM) +73%. Genfit (NASDAQ:GNFT) +44%. Bellerophon Therapeutics (NASDAQ:BLPH) +27%. Spruce Biosciences (NASDAQ:SPRB) +25%. AMC Entertainment Holdings (NYSE:AMC) +21%. Stran & Company (NASDAQ:STRNW) +22%. AeroCentury (NYSE:ACY) +19%. cbdMD (NYSE:YCBD) +19%. Net 1 U...
News, Short Squeeze, Breakout and More Instantly...
Spruce Biosciences Inc. Company Name:
SPRB Stock Symbol:
NASDAQ Market:
Spruce Biosciences Inc. Website:
Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, announced that the San Francisco Business Times and the Silicon Valley Busines...
Pairs Spruce’s Investigational Product Candidate, Tildacerfont, with HMNC’s Companion Diagnostic, the Proprietary Cortibon Genetic Selection Tool, to Treat MDD Patients Responsive to CRF 1 Receptor Antagonism Provides Spruce with Option to In-License Exclusive Worldwide ...
Significant Reduction in Dehydroepiandrosterone Sulfate ( DHEAS) Versus Placebo Observed in Women with Elevated DHEAS Levels at Baseline Increase in Serum Sex Hormone Binding Globulin (SHBG) Versus Placebo Observed Tildacerfont was Well-Tolerated with No Safety Signals ...